# FDA Inspection 1310204 - Octapharma Plasma Inc - March 19, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/09cd8fb6-232f-4d8e-975b-eafd615c1dab
Source feed: FDA_Inspections

> FDA Inspection 1310204 for Octapharma Plasma Inc on March 19, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310204
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2026-03-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1317018 - 2026-04-22](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9e98c991-9662-4cc4-98e6-03ba4e0f3496)
- [FDA Inspection 1312082 - 2026-03-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f269ae61-075b-4e5a-ac6f-ca5b5173d328)
- [FDA Inspection 1282432 - 2026-03-11](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d5d89e9c-0cf4-4184-afba-0f843912dcdf)
- [FDA Inspection 1297590 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a7f2fd75-f1f1-4f3f-aa3b-aa38cb5b533d)
- [FDA Inspection 1250909 - 2024-08-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/02cffa56-07c0-46df-9718-1a7f7ca48c58)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/620b62aa-2a97-4307-a10b-c2402da97705

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d